BILLERICA, Mass.--(BUSINESS WIRE)--
Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless
insulin pump technology with its Omnipod® Insulin
Management System, today announced that management will present at three
upcoming investor conferences in New York City, New York:
This Smart News Release features multimedia. View the full release here:
The 2017 Wedbush PacGrow Healthcare Conference on Tuesday, August 15,
2017 at 9:10 a.m. (Eastern Time).
The Baird 2017 Global Healthcare Conference on Wednesday, September 6,
2017 at 8:30 a.m. (Eastern Time).
The Morgan Stanley Global Healthcare Conference on Monday, September
11, 2017 at 4:50 p.m. (Eastern Time).
To listen to live audio webcasts of the presentations, please visit http://investors.insulet.com/.
Replays of the webcasts will also be available following the events.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD) is an innovative medical device
company dedicated to making the lives of people with diabetes easier.
Through its Omnipod Insulin Management System, Insulet seeks to expand
the use of insulin pump therapy among people with insulin-dependent
diabetes. The Omnipod is a revolutionary and easy-to-use tubeless
insulin pump that provides up to three days of non-stop insulin
delivery, without the need to see or handle a needle. Insulet's Delivery
Systems business also partners with global pharmaceutical and
biotechnology companies to adapt the Omnipod technology platform for the
delivery of subcutaneous drugs across multiple therapeutic areas.
Founded in 2000, Insulet Corporation is based in Billerica,
Massachusetts. For more information, please visit: http://www.myomnipod.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170801005214/en/
Investor Relations and Media Contact:
Vice President, Investor Relations and
Source: Insulet Corporation
News Provided by Acquire Media